#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3274	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1980	292.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	348	C	207	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	282.1	0	.	n	.	0	T695C	SNP	695	695	T	1188	1188	C	326	C	188	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	282.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1830	1830	A	303	A	183	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	282.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2464	2464	C	287	C	174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	282.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2538	2538	A	324	A	192	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	282.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3090	3090	C	322	C,T	196,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	27	322	folP	852	852	100.0	folP.l6.c17.ctg.1	1650	33.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1118	1120	AGC	44;45;44	A;G;C	27;27;25	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	818	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3152	46.6	1	SNP	p	S91F	1	.	.	271	273	TTC	483	485	TTC	56;56;56	T;T;C	36;34;34	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	818	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3152	46.6	1	SNP	p	D95N	1	.	.	283	285	AAC	495	497	AAC	56;56;56	A;A;C	32;32;33	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	818	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3152	46.6	1	SNP	p	N95G	0	.	.	283	285	AAC	495	497	AAC	56;56;56	A;A;C	32;32;33	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Z_01455	mtrR.WHO_Z_01455	1	1	27	264	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1231	40.1	1	SNP	p	G45D	0	.	.	133	135	GGC	405	407	GGC	79;79;79	G;G;C	45;47;46	mtrR.WHO_Z_01455:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	194	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	706	44.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	700	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3034	40.1	1	SNP	p	D86N	0	.	.	256	258	GAC	528	530	GAC	43;43;43	G;A;C	24;19;24	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	700	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3034	40.1	1	SNP	p	R87I	0	.	.	259	261	CGT	531	533	CGT	43;43;41	C;G;T	25;23;20	parC.WHO_X_00208c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	700	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3034	40.1	1	SNP	p	S87R	1	.	.	259	261	CGT	531	533	CGT	43;43;41	C;G;T	25;23;20	parC.WHO_X_00208c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	700	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3034	40.1	1	SNP	p	R87W	0	.	.	259	261	CGT	531	533	CGT	43;43;41	C;G;T	25;23;20	parC.WHO_X_00208c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	700	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3034	40.1	1	SNP	p	S88P	1	.	.	262	264	CCC	534	536	CCC	41;41;41	C;C;C	23;27;26	parC.WHO_X_00208c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	574	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2421	43.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1439	1441	GGC	27;27;27	G;G;C	17;18;18	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1298	1300	GCC	72;72;72	G;C;C	43;43;43	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1301	1303	ATG	72;72;72	A;T;G,A	43;44;43,1	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1313	1315	ACC	70;70;66	A;C;C	42;43;41	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1313	1315	ACC	70;70;66	A;C;C	42;43;41	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1814	1816	ACC	43;43;43	A;C;C	25;25;27	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1868	1870	GCG	50;49;49	G;C;G	31;29;29	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1868	1870	GCG	50;49;49	G;C;G	31;29;29	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1991	1993	GGT	50;52;49	G;G;T	31;34;32	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2000	2002	AGC	48;48;49	A;G;C	31;30;31	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	720	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	52.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2018	2020	CCG	49;49;49	C;C;G	29;31;31	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1348	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3103	67.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1624	1626	CCG	31;31;31	C;C;G	18;20;19	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	382	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1972	35.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	39	C	23	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	412	porB1b	1047	1047	99.9	porB1b.l15.c4.ctg.1	1613	45.4	0	.	p	.	0	D121G	NONSYN	361	363	GAC	626	628	GGC	55;55;55	G;G;C	35;33;33	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	412	porB1b	1047	1047	99.9	porB1b.l15.c4.ctg.1	1613	45.4	1	SNP	p	G120K	1	.	.	358	360	AAG	623	625	AAG	51;51;53	A;A;G	33;34;33	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1758	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4766	64.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	172	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1058	29.7	1	SNP	p	V57M	1	.	.	169	171	ATG	654	656	ATG	53;53;59	A;T;G	34;34;37	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
